Fzata Announces the Appointment of A New Board Member
16 May 2025 //
PR NEWSWIRE
C. difficile Clinical Trial Agreement for Fzata`s FZ002
11 Mar 2025 //
PR NEWSWIRE
Fzata, Inc. Announces Multi-million Dollar NIH Grant
24 Sep 2024 //
PR NEWSWIRE
Fzata is a Start-Up Stadium Finalist at BIO 2024
14 May 2024 //
PR NEWSWIRE
Fzata Raising Series A For New Oral Biologics Platform Modality
26 Jan 2023 //
PR NEWSWIRE